Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Government warns against proposed NHI premium exemptions for seniors
12/30/2024 09:57 PM - Politics
Taiwan's Presidential Office expresses condolences following Carter's death
12/30/2024 09:45 PM - Society
Minister worries opposition bill will upend live-in caregiver market
12/30/2024 08:57 PM - Society
Taiwan revises 2030 carbon reduction target upwards
12/30/2024 08:27 PM - Business
Hon Hai to demonstrate EVs, automotive electronics at CES
12/30/2024 07:49 PM